SI-BONE, Inc. (SIBN), a medical device company specializing in sacropelvic disorder solutions, is scheduled to present at the Piper Sandler 37th Annual Healthcare Conference in New York, with management hosting a fireside chat on December 2, 2025.
The company recently reported financial results for the third quarter ended September 30, 2025, and updated its full-year guidance.
Net loss narrowed to $4.6 million, or $0.11 per share from $6.6 million, or $0.16 per share, in Q3 2024, reflecting improved leverage and disciplined expense management.
iFuse Bedrock Granite and TORQ TNT remain SI-BONE's major revenue-generating products.
Total revenue rose to $48.7 million in Q3, 2025, up 19% from $40.3 million in Q3 2024.
The U.S. revenue accounted for $45.4 million, an 18% increase from $38.3 million in Q3 2024, driven by strong demand. International revenue for the third quarter of 2025 was $2.3 million, up 10.2% from $2.1 million a year earlier, underscoring steady expansion in overseas markets.
Gross margin remained stable at approximately 79.8%.
Cash, cash equivalents, and marketable securities stood at $145.7 million at the end of Q3 2025, compared with $150.8 million at the end of Q3 2024, reflecting disciplined cash management despite growth investments.
Looking ahead, SI-BONE expects fiscal year 2025 revenue to be in the range of $190 million to $192 million, compared with $167.2 million reported in fiscal year 2024.
SIBN has traded in the range of $11.70 to $20.05 over the past year. The stock closed yesterday's trading at $18.36, up 2.46%.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.